purpose assess clinical results spot scanning proton beam radiation therapy pt treatment skull base chordomas chondrosarcomas cs methods materials october NUMBER october NUMBER NUMBER patients median age NUMBER years chordomas n NUMBER cs n NUMBER treated paul scherrer institut psi protons using main cyclotron tumor conformal application proton beams realized spot scanning technology median chordoma cs dose NUMBER NUMBER cobalt gy equivalent respectively cobalt gy equivalent proton gy x NUMBER median gross tumor volumes gtv NUMBER ml range ml NUMBER ml range ml chordoma cs respectively late toxicity assessed using national cancer institute common terminology criteria adverse events ctcae v30 grading median time NUMBER months range months results actuarial local control rates NUMBER NUMBER chordoma cs respectively observed surgical pathway marginal failure patients chordomas regional failure distant metastasis observed NUMBER years actuarial pfs os entire cohort NUMBER NUMBER respectively actuarial complicationfree survival NUMBER pituitary dysfunction observed NUMBER NUMBER patients ctcae grade NUMBER patient presented brainstem optic pathways necrosis dysfunction univariate analysis age NUMBER years time pt affected favorably pfs p NUMBER conclusion pt offers high tumor control rates skull base chordoma cs results compare favorably combined carbon ion irradiation series observed toxicity acceptable younger age NUMBER years favorable prognostic factor pfs preliminary results encouraging confirmed longer low grade NUMBER mev NUMBER NUMBER NUMBER NUMBER follow NUMBER NUMBER NUMBER year NUMBER year radiation induced post pt spot scanning proton photon follow